Clinical trials: Muslim
Type II Diabetes Mellitus
Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus
To compare the safety and efficacy of empagliflozin versus other treatments in Pakistani Muslim population with type II diabetes mellitus.
- Trial name
- SAFE-PAK (NCT04665284)
- Testing
- Empagliflozin, Usual care group
- Where
- 11 sites in Pakistan
- Volunteers
- 244 people, healthy volunteers welcome
- Sponsor
- Getz Pharma